Keyphrases
Adult Patients
13%
Aggressive Disease
13%
B-cell Malignancies
13%
Cell Tumor
5%
Cellular Gene Expression
13%
Cellular Immunotherapy
41%
Cellular Origin
13%
Clinical Outcomes
13%
Disease Biology
13%
Effector Memory T Cells
5%
Encoded Protein
11%
Epithelial Malignancies
13%
Epitope
5%
Epstein-Barr Virus
100%
Epstein-Barr Virus Infections
13%
Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis
41%
Epstein-Barr Virus-positive
41%
Exon
5%
Extranodal
47%
Fresh Tissue
13%
Functional Studies
13%
Hemophagocytic Lymphohistiocytosis
13%
Hodgkin Lymphoma
5%
Immuno
5%
Immunogenicity
5%
Immunotherapy Targets
5%
Latency
5%
Latent Membrane Protein 1 (LMP1)
41%
LMP2A
17%
Lymphoma
41%
Lymphoma Subtype
13%
Lymphomagenesis
19%
Lymphoproliferative Disorders
5%
Lymphotropic
13%
Malignancy
25%
Molecular Study
13%
Natural Killer Cells
96%
Novel Transcripts
5%
Optimal Target
5%
Pathobiology
27%
Post-transplant Lymphoproliferative Disorder
5%
Primary Extranodal
5%
Rare Diseases
13%
T Cells
39%
T-cell Lymphoma
52%
T-cell Lymphoproliferative Disorder
41%
Terminal Repeat
5%
Therapeutic Targeting
5%
Tumor
19%
Viral
13%
Viral Gene Expression
13%
Viral Genome
41%
Virus
19%
Virus Genome
13%
Immunology and Microbiology
Cytotoxic T-Cell
8%
Epitope
8%
Epstein Barr Virus
82%
Exon
8%
Hemophagocytic Lymphohistiocytosis
41%
Immunogenicity
8%
Immunotherapy
41%
Intravenous Immunoglobulin
8%
Natural Killer Cell
82%
Natural Killer T Cell
8%
Promoter Region
8%
T Cell
48%
Viral Disease
6%
Virus
8%
Virus Genome
41%
Medicine and Dentistry
B Cell
10%
Cancer
20%
Diseases
10%
Epstein Barr Virus
41%
Gene Expression
10%
Natural Killer Cell
10%
Neoplasm
10%
NK T Cell Lymphoma
30%
T Cell
10%
Virus
10%